Literature DB >> 7553620

bcl-2 suppresses expression of p21WAF1/CIP1 in breast epithelial cells.

S Upadhyay1, G Li, H Liu, Y Q Chen, F H Sarkar, H R Kim.   

Abstract

The tumor suppressor gene p53 regulates G1 checkpoint prior to the initiation of DNA synthesis, which can either induce G1 arrest or signal apoptosis. The involvement of p53 in apoptosis may also be related to its ability to down-regulate transcription of the bcl-2 gene. The bcl-2 gene product prevents most types of apoptotic cell death, suggesting that bcl-2 interferes with an essential signaling molecule involved in the apoptotic cell death pathway. Although the bcl-2 protein is shown to be overexpressed in many types of human tumor including breast cancer, its biochemical or pathological consequences are poorly understood. To determine the effects of bcl-2 overexpression on apoptosis and transformation of breast epithelial cells and to investigate whether bcl-2 interferes with the p53 pathway, we introduced the bcl-2 expression vector into MCF10A cells, which were derived from diploid human breast epithelial cells containing the wild-type p53 gene. Overexpression of bcl-2 prevented free radical-induced apoptosis and induced a partially transformed phenotype in MCF10A cells. Although overexpression of bcl-2 did not affect the expression of the p53 gene, p53-dependent gene transcription such as p21WAF1/CIP1 was suppressed. These results suggest that bcl-2 may inhibit p53 functional activity and is involved in the regulation of an early commitment step either to proliferate or suicide.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7553620

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Enhanced apoptotic response to photodynamic therapy after bcl-2 transfection.

Authors:  H R Kim; Y Luo; G Li; D Kessel
Journal:  Cancer Res       Date:  1999-07-15       Impact factor: 12.701

2.  A demon in the bathroom.

Authors:  F R van de Goot; R L ten Berge
Journal:  J Clin Pathol       Date:  2001-11       Impact factor: 3.411

Review 3.  [Significance of apoptotic processes in radiotherapy. I].

Authors:  M Abend; D van Beuningen
Journal:  Strahlenther Onkol       Date:  1998-03       Impact factor: 3.621

4.  p21(waf) correlates with DNA replication but not with prognosis in invasive breast cancer.

Authors:  U J Göhring; A Bersch; M Becker; W Neuhaus; T Schöndorf
Journal:  J Clin Pathol       Date:  2001-11       Impact factor: 3.411

5.  Patterns of p21(waf1/cip1) expression in non-papillomatous nasal mucosa, endophytic sinonasal papillomas, and associated carcinomas.

Authors:  M J Schwerer; A Sailer; K Kraft; K Baczako; H Maier
Journal:  J Clin Pathol       Date:  2001-11       Impact factor: 3.411

6.  Regulation of expression of the multidrug resistance protein MRP1 by p53 in human prostate cancer cells.

Authors:  G F Sullivan; J M Yang; A Vassil; J Yang; J Bash-Babula; W N Hait
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

7.  Prognostic significance of bcl-2 and p53 expression in colorectal carcinoma.

Authors:  Dan-ping Zhao; Xiao-wen Ding; Jia-ping Peng; Yi-xiong Zheng; Su-zhan Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2005-12       Impact factor: 3.066

8.  Prognostic factors in resectable pancreatic cancer: p53 and bcl-2.

Authors:  R J Bold; K R Hess; A S Pearson; A M Grau; F A Sinicrope; M Jennings; D J McConkey; C D Bucana; K R Cleary; P A Hallin; P J Chiao; J L Abbruzzese; D B Evans
Journal:  J Gastrointest Surg       Date:  1999 May-Jun       Impact factor: 3.452

9.  Microarray and pathway analysis reveals decreased CDC25A and increased CDC42 associated with slow growth of BCL2 overexpressing immortalized breast cell line.

Authors:  Jacquelyn M Long; Charles W Bell; W Samuel Fagg; Mary E Kushman; Kevin G Becker; James A McCubrey; Mary A Farwell
Journal:  Cell Cycle       Date:  2008-10-08       Impact factor: 4.534

10.  Cell cycle regulation and differentiation in the human podocyte lineage.

Authors:  M Nagata; K Nakayama; Y Terada; S Hoshi; T Watanabe
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.